Skip to main content
Fig. 8 | Journal of Hematology & Oncology

Fig. 8

From: Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer

Fig. 8

Clinical significance of GSTM3TV2 expression in patients with pancreatic cancer. a GSTM3TV2 expression in pancreatic cancer and tumour-adjacent tissues was analysed by ISH. b The expression levels of GSTM3TV2 were significantly increased in 180 pancreatic cancer tissue samples compared with those matched tumour-adjacent tissues as analysed using the Pearson χ2 test. c Kaplan-Meier survival analysis revealed that high levels of GSTM3TV2 expression in tumours were significantly associated with reduced survival in patients with pancreatic cancer. d High levels of GSTM3TV2 expression in tumour-adjacent tissues were not significantly associated with overall survival in patients

Back to article page